Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  esomeprazole magnesium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: KMU-IRB00003151, VGHKS95-CT3-11, NCT00656968
VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113971, NCT01205230
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D9612C00025, NCT00079833
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000491649, OCTO-003, 2004-003836-77, ISRCTN85156844, OCTO-ASPECT, RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, EU-20628, NCT00357682
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00838, MAY04-4-01, CDR0000544180, MAYO-MAY04-4-01, N01CN35000, NCT00474903
Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Fudan BR2010-01, NCT01069081
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109275, NCT00849329
Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C14015, NCT01844583
Nexium Capsules Clinical Experience Investigation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D961HC00010, NCT01434485
Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D961HC00011, NCT01435525
Start Over